Molecular Aspects of Cancer

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/27

flashcard set

Earn XP

Description and Tags

A collection of flashcards summarizing key concepts and facts from the lecture on the molecular aspects of cancer.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

28 Terms

1
New cards

What are the original Hallmarks of Cancer (2000)?

Self-sufficiency in growth signals, insensitivity to inhibitory signals, altered metabolism, evasion of apoptosis, limitless replication, angiogenesis, metastasis, immune evasion.

2
New cards

What growth factors are mitogenic?

PDGF, EGF

3
New cards

What is an example of a growth-inhibitory factor?

TGF-β

4
New cards

What does PDGF do?

Stimulates division in connective tissue and nervous system development.

5
New cards

What family does EGFR belong to?

ErbB family of Receptor Tyrosine Kinases (RTKs).

6
New cards

Why are RTK mutations oncogenic?

They cause sustained proliferative signaling.

7
New cards

What is the Restriction (R) point?

The point at which a cell commits to division.

8
New cards

Which CDKs target pRB?

CDK4/6 (before R) and CDK2 (after R).

9
New cards

What happens when RB1 is inactivated?

Cells evade growth suppression, contributing to cancer.

10
New cards

What does mismatch repair (MMR) fix?

Mismatch repair (MMR) fixes replication errors that are not corrected by DNA polymerase, such as base-base mismatches and insertion-deletion loops that occur during DNA replication. This process involves the recognition of the mismatch by MMR proteins, excision of the erroneous DNA segment, and resynthesis of the correct DNA sequence, thereby maintaining

11
New cards

What is Lynch Syndrome?

A hereditary condition caused by defective MMR, increasing cancer risk.

12
New cards

Which proteins are involved in MMR?

MutS (MSH2/MSH6), MutL (MLH1/PMS2).

13
New cards

What is microsatellite instability (MSI)?

Microsatellite instability (MSI) is a condition of genetic hypermutability that results from the loss of DNA mismatch repair (MMR) capability. It is characterized by alterations in the length of microsatellites, which are short, repetitive sequences in the genome. Excessive mutation rates in these regions can indicate a higher likelihood of developing certain cancers, particularly colorectal cancer. MSI is considered a significant biomarker for MMR deficiency, which may suggest a potential response to immunotherapy treatments, such as immune checkpoint inhibitors

14
New cards

What does the DDR pathway do?

Signals and coordinates response to DNA damage.

15
New cards

What are examples of direct DNA repair?

Photolyase, Methyltransferase, Oxidative demethylase.

16
New cards

What is BER?

Base Excision Repair – fixes small lesions like oxidative damage.

17
New cards

What is NER?

Nucleotide Excision Repair – removes bulky lesions like UV damage.

18
New cards

What is HR?

Homologous Recombination – error-free repair using sister chromatid.

19
New cards

What is NHEJ?

Non-Homologous End Joining – quick, error-prone DSB repair.

20
New cards

What causes Xeroderma Pigmentosum?

Defective NER genes (e.g., XPA, XPC, XPB).

21
New cards

What does BRCA1 do?

Links DNA damage sensing to repair.

22
New cards

What does BRCA2 do?

Recruits RAD51 for homologous recombination.

23
New cards

What happens when ATM is mutated?

Leads to Ataxia Telangiectasia with cancer and neurological risks.

24
New cards

What stimulates Cyclin D expression?

Mitogen signaling through RTKs.

25
New cards

What are the CDK-cyclin pairs by phase?

G1: Cyclin D/CDK4/6, G1–S: Cyclin E/CDK2, S: Cyclin A/CDK2, G2–M: Cyclin B/CDK1.

26
New cards

What are the main CDK inhibitors?

INK4 (e.g., p16) and Cip/Kip (e.g., p21).

27
New cards

How do Cyclin Kinase Inihibitors work?

Block cyclin-CDK ATP-binding site, halting kinase activity.

28
New cards

What is the main takeaway about cancer cell cycles?

Cancer results from deregulation of cell cycle and loss of control by checkpoints.